On a GLP-1? Here's What Your Doctor Should Be Monitoring
GLP-1s do more than help you lose weight. Learn what should be monitored—muscle mass, nutrients, and metabolic markers—while you're on one.

Primary care, functional medicine, and wellness. All under one roof. We're built for your best not your baseline.
Learn MoreGLP-1 medications like semaglutide and tirzepatide have become one of the most talked-about tools in weight management and metabolic health. They're effective, often dramatically so, at supporting weight loss and improving blood sugar control. But effectiveness on the scale doesn't mean the conversation should stop there. What happens in the body while you're on a GLP-1, and after, matters just as much as the number on the scale.
What GLP-1s Actually Do
GLP-1 receptor agonists work by mimicking a naturally occurring hormone that regulates appetite, slows gastric emptying, and improves insulin sensitivity. The result is reduced hunger, better blood sugar control, and often significant weight loss. For people with obesity or type 2 diabetes, the metabolic benefits can be substantial. But rapid, significant weight loss, regardless of the method, comes with downstream effects that are easy to overlook if no one is tracking them.
What Often Gets Missed
The most well-documented concern with GLP-1-driven weight loss is the loss of lean muscle mass alongside fat. Studies have found that a meaningful percentage of total weight lost on GLP-1s can come from lean tissue rather than fat, which has implications for metabolic rate, strength, and long-term body composition. Beyond muscle loss, rapid weight change can also affect:
- Nutrient status — reduced food intake can lead to deficiencies in protein, vitamins, and minerals if not actively managed
- Bone density — significant weight loss is associated with bone density changes, particularly relevant for women and older adults
- Metabolic markers — while many markers improve, ongoing monitoring of fasting insulin, lipids, and inflammation is still essential to understand the full picture
- Sustainability — without a plan for nutrition, strength training, and eventual medication tapering, weight regain after stopping is common
What Should Be Monitored While on a GLP-1
A medication this powerful deserves more oversight than a prescription and a follow-up call. A comprehensive approach typically includes:
- Baseline and ongoing body composition assessment, not just weight
- Protein intake and strength training guidance to preserve lean muscle mass
- Nutrient panels to catch and correct deficiencies early
- Regular lab monitoring of metabolic markers — fasting insulin, lipids, and inflammation — to track the full picture, not just the scale
- A long-term plan for what happens after the medication, whether that's tapering, maintenance, or lifestyle-based sustainability
Why This Requires a Coordinated Team
GLP-1s are often prescribed through telehealth platforms or specialty weight-loss clinics that aren't connected to the rest of your healthcare. That disconnect means the person managing your medication may not be the same person tracking your nutrient levels, bone health, or cardiovascular markers and the gaps between those data points are exactly where issues go unnoticed.
How The Lanby Can Help
At The Lanby, GLP-1 management is integrated into your full picture of care, not handled in isolation. Metabolic health and nutrient health are two of our four foundational pillars, which means your Care Team monitors the markers that matter most while on a GLP-1 — body composition, nutrient status, and metabolic labs — alongside everything else going on with your health, so nothing falls through the cracks.
If you're on a GLP-1 or considering one, schedule a complimentary Discovery Call to learn how The Lanby can help you use it safely, effectively, and as part of a coordinated long-term health plan.

Book a complimentary Discovery Call to learn about our membership, discover how your dedicated care team will support you, get your questions answered, and see if The Lanby is the right fit for you.

Kendall is a graduate of the University of Mississippi, with a B.A. in Integrated Marketing Communications and a minor in Business Administration. She received her certificate of Nutrition Science from the Friedman School of Nutrition at Tufts University.

Chloe holds a bioengineering degree from the University of Pennsylvania. As a breast cancer survivor, her insights shape The Lanby's patient-centric approach. Leveraging her healthcare strategy background, Chloe pioneers concierge medicine, bridging gaps in primary care.

Tandice was recognized with the Health Law Award and named a Ruth Bader Ginsburg Scholar at Columbia Law School. Tandice's editorial role is enriched by her insights into patient autonomy and gene modification legalities. Passionate about bioethics, she is committed to crafting patient-centric healthcare solutions.

.avif)



